Goldman Sachs cuts Charles Schwab stock price target on NII outlook

Goldman Sachs cut its Charles Schwab price target to $117 from $122 and lowered its 2026–2028 EPS estimates, while maintaining a Buy rating, citing a weaker net interest income outlook. Third-quarter deposits fell 2% to $244 billion, although Schwab beat adjusted EPS estimates at $1.69 versus $1.66; revenue of $7.17 billion missed the $7.2 billion forecast. Solid expense management and about 6% net new asset growth partly offset concerns about deposit outflows and cash-sweep revenue risks.

Analysis

SCHW’s key asymmetry is that the earnings recovery depends not just on rates, but on whether deposits stabilize enough for higher rates to translate into better funding economics. Deposit attrition can blunt asset-yield benefits through a worse funding mix; continued net new asset growth is supportive, but does not by itself resolve that mismatch. Management’s explanation that outflows reflect client activity rather than sorting is plausible, not yet proof that cash-sweep economics are durable.

The valuation discount offers a cushion, but not a catalyst on its own. Goldman’s 2027 EPS reduction from $7.97 to $7.74 is about 3%—a modest estimate reset that highlights how even a lower multiple can be vulnerable if deposit and NII expectations keep drifting down. Conversely, the gap between asset gathering and deposits creates room for sentiment to improve if cash balances stabilize and the stated NII recovery into 2027–28 becomes visible in reported results. AI tools are not a near-term earnings driver on the evidence provided; restricting third-party access may protect account control, but could also constrain customer utility if competing platforms become preferred interfaces.

Near term, the next deposit, cash-sweep and NIM disclosures matter more than the analyst target changes. Over 6–18 months, the thesis turns on whether NII improves without renewed funding pressure. The contrarian opportunity is that investors may be treating cash migration as franchise deterioration; the opposing risk is that a persistent mix shift makes the projected recovery too optimistic.

Key Decisions for Investors

• Consider a staged long in SCHW rather than chasing an immediate re-rating: the supplied 12x 2027 P/E and continued asset gathering provide support, while the next quarterly disclosure is the near-term confirmation point. Size against the possibility that the discount persists.
• Add only if reported deposits/cash balances stabilize and management maintains the NII/NIM recovery trajectory into 2027. Falsify the thesis if deposit declines continue alongside a downward revision to that trajectory or evidence that cash-sweep economics are deteriorating faster than expected.
• Do not treat Goldman’s lower target as a standalone catalyst or the article’s fair-value/PEG claims as independent validation. Track actual deposit trends, cash-sweep balances, NIM and expense execution; analyst estimate changes are secondary until those operating indicators confirm a turn.
• No high-conviction sector pair is established by this item: it provides no comparable competitor deposit or sweep data. Revisit relative value only after comparing those metrics across brokers and custodians.